金属支架联合立体定向适形放疗治疗肝门部胆管癌  

Metallic stent and stereotactic conformal radiotherapy for hilar cholangiocarcinoma

作　　者：李玉[1] 王宁[1] 田起和[1] 郭占文[1] 张海波[1] 宋丽艳[1] 

机构地区：[1]解放军沈阳军区总医院放射肿瘤介入科,沈阳110015

出　　处：《中华放射肿瘤学杂志》2005年第1期39-41,共3页Chinese Journal of Radiation Oncology

摘　　要：目的评价金属支架联合立体定向适形放疗肝门部胆管癌的疗效。方法31例肝门部胆管癌患者行金属支架置入联合立体定向适形放疗,并与23例行单纯支架治疗者进行对比研究。结果联合治疗组生存时间平均为11.1个月;对照组为5.1个月,差异有显著性意义(P<0.01)。结论胆道金属支架置入联合立体定向适形放疗是不能手术肝门部胆管癌的一种有效治疗方法。Objective Toevaluatetheeffectofmetallicstentcombinedwithstereotacticconformalradio therapy (SCRT)forhilarcholangiocarcinoma.Methods Fifty fourpatientswithhilarcholangiocarcinomawere analyzed ,including 31treatedwithstentplusstereotacticconformalradiotherapy (combinedgroup)and 2 3with metallicstentalone (controlgroup) .Results Themeansurvivaltimeofcombinedgroupwas 11.1± 4 .6 months,comparedwith 5 .1± 2 .8monthsofthecontrolgroup ,givingasignificantdifferencebetweenthetwo groups (P <0 .0 1) .Conclusion Thecombinationofmetallicstentandstereotacticconformalradiotherapyis moreeffectivethanmetallicstentaloneforunresectablehilarcholangiocarcinoma .

关 键 词：金属支架 立体定向适形放疗 肝门部 胆管癌 肿瘤 肝门部 HBDC 

分 类 号：R735.8[医药卫生—肿瘤]